I'm surprised no one has discussed this.
Mithra now owns a significant chunk of Mayne pharma and this is a significant milestone.
There will likely be pressure on Mayne pharma to do better from Mithra, particularly as Mithra was promised a board member position as well.
I still feel like it's going to take actual sales figures to change sentiment on this stock but this could be a turning point.
Ann: Appendix 2A and Notice under ASX Listing Rule 3.10A, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$4.98 |
Change
-0.040(0.80%) |
Mkt cap ! $405.4M | |||
| Open | High | Low | Value | Volume |
| $5.00 | $5.00 | $4.94 | $102.5K | 20.67K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 727 | $4.97 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.99 | 2790 | 7 |
View Market Depth
| Last trade - 11.37am 26/06/2025 (20 minute delay) ? |
| MYX (ASX) Chart |